Has ThermoGenesis Peaked?
ThinkstockThermoGenesis Corp. (NASDAQ: KOOL) is seeing a day-two run in its stock, but investors might want to pay close attention here. The reality is that with a market cap under $50 million, this is…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 297Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside
Here are some of the top biotech names to buy at Cowen. They presented such an extensive list that we focused on the quality large cap names and the stocks with the highest upside…
Teva Acquisition Machine Gears Up: Who Is the Next Target?
Teva Pharmaceutical resume a deal-making strategy that made it one of the most acquisitive drug companies of the past decade. Could one of these biotech takeover candidates be the next target?
Piper Jaffray Has Four Biotech Stocks to Buy With Huge Potential
The analysts at Piper Jaffray have returned from meeting with some of the top biotechs the cover, and they have gleaned some interesting morsels that could be huge as the year wears on.
Strong Growth Lifts UnitedHealth Earnings
Before markets opened Thursday morning, UnitedHealth Group reported fourth-quarter and full-year 2013 results that topped consensus estimates on the top and bottom lines.
Can Chelsea Live Up to Its Potential This Time?
Chelsea Therapeutics International is on the leader board for percentage gains on Thursday, with a rise of 111% or so. And it isn't even on news of a buyout. Can the company live up…
UBS Has Nine Biotech Buyout and Merger Candidates
The analysts at UBS are not only bullish on the biotechnology sector, they think there is a very distinct possibility that some of the top names may also become takeover targets this year.
Higher 2017 Celgene Guidance Keeps Confusion in Near-Term
Celgene has issued its preliminary numbers ahead of its presentations at the 32nd Annual J.P. Morgan Healthcare Conference. There is some confusion over near-term guidance, which hit the stock a bit.
Volatility and Options in MannKind Shaking Speculators Out
ThinkstockMannKind Corp. (NASDAQ: MNKD) is a stock that has been on a wild ride for many years. The company’s inhalable insulin has been held up from being approved for years as well. That seems…
Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire
Piper Jaffray analyst have a list of top biotech stock picks that could bring big gains for investors. The look for high-conviction near-term binary events and lower conviction catalysts with negligible downside.
Merrill Lynch Top Medical Technology Stocks to Buy for 2014
At this time last year, the sentiment on Wall Street for the medtech sector was very poor. The bearish sentiment that prevailed in January of 2013 is gone, but expectations are still tempered. That…
The Bullish and Bearish Case for UnitedHealth in 2014
UnitedHealth Group is still relatively new as a member of the Dow Jones Industrial Average. Its stock gained a whopping 41% in 2013. Now the question is how well it can do for investors…
J.P. Morgan Top Biotechnology Stocks to Buy for 2014
Biotechnology was an incredible performer in 2013. The analysts at J.P. Morgan think that the huge outperformance may lessen going forward but can stay intact. They think the fundamental backdrop is very similar to…
The Bullish and Bearish Case for Pfizer and Merck in 2014
With a new year comes new expectations. 24/7 Wall St. has generated a bullish and bearish scenario for 2014 in each stock of the Dow, including Pfizer and rival Merck & Co.
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More
The team at Oppenheimer has a list of biotech stocks to buy that feature catalysts that could be game changers. They all have 50% or higher upside to the firm's price target.